James N Topper's Net Worth

$721 Million

Who is James N Topper?

James N Topper has an estimated net worth of $721 Million. This is based on reported shares across multiple companies, which include GLAUKOS Corp, Tarsus Pharmaceuticals, Inc., ALPINE IMMUNE SCIENCES, INC., COLLEGIUM PHARMACEUTICAL, INC, Phathom Pharmaceuticals, Inc., ANAPTYSBIO, INC, Sierra Oncology, Inc., Mirum Pharmaceuticals, Inc., AMICUS THERAPEUTICS INC, Frazier Lifesciences Acquisition Corp, Allena Pharmaceuticals, Inc., Entasis Therapeutics Holdings Inc., Passage BIO, Inc., Arcutis Biotherapeutics, Inc., LA JOLLA PHARMACEUTICAL CO, Aptinyx Inc., HilleVax, Inc., and PORTOLA PHARMACEUTICALS INC.

SEC CIK

James N Topper's CIK is 0001341382

Past Insider Trading and Trends

2008 was James N Topper's most active year for acquiring shares with 802 total transactions. James N Topper's most active month to acquire stocks was the month of January. 2020 was James N Topper's most active year for disposing of shares, totalling 13 transactions. James N Topper's most active month to dispose stocks was the month of May. 2022 saw James N Topper paying a total of $73,012,773.50 for 4,902,805 shares, this is the most they've acquired in one year. In 2020 James N Topper cashed out on 18,521,235 shares for a total of $250,010.00, their largest year based on trade value.